135 related articles for article (PubMed ID: 6647463)
1. Cell biological systems for prediction of individual human tumor drug sensitivity.
Tanneberger S; Nissen E
Prog Clin Biol Res; 1983; 132E():129-43. PubMed ID: 6647463
[No Abstract] [Full Text] [Related]
2. In vitro studies of human tumor and embryonic tissue.
Allen A; Ramon T; Jacobson A; Wade ME
Trans Pac Coast Obstet Gynecol Soc; 1972; 40():8-14. PubMed ID: 4356757
[No Abstract] [Full Text] [Related]
3. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
Zhukova OS; Dobrynin IaV
Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
[TBL] [Abstract][Full Text] [Related]
4. [Attempt in determination of the sensitivity of ovarian neoplasms with ascites to cytostatics in tissue cultures].
Králová A
Cesk Gynekol; 1971 Sep; 36(7):437-8. PubMed ID: 5110668
[No Abstract] [Full Text] [Related]
5. [Investigations for using cell- and organ culture in sensibility tests for cytostatics in human ovarial-carcinomas (author's transl)].
Hecker D; Saul G; Wolf G
Arch Geschwulstforsch; 1976; 46(1):34-43. PubMed ID: 962500
[TBL] [Abstract][Full Text] [Related]
6. [Studies into dependence of sensitivity of cytostatics on overlap index of ovarian cancer in cell cultures (author's transl)].
Schindler C
Zentralbl Gynakol; 1982; 104(3):156-9. PubMed ID: 7043954
[TBL] [Abstract][Full Text] [Related]
7. [Anticytogram (author's transl)].
Ciuffi M
Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():662-72. PubMed ID: 400252
[TBL] [Abstract][Full Text] [Related]
8. Modern chemotherapy in solid tumours.
Kaye SB
Q J Med; 1994 Jun; 87(6):319-22. PubMed ID: 8041863
[No Abstract] [Full Text] [Related]
9. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
[TBL] [Abstract][Full Text] [Related]
10. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
Maraninchi D; Droz JP
Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
[TBL] [Abstract][Full Text] [Related]
11. [Cytostatics for improvement of clinical tumor surgery].
Rieche K
Zentralbl Chir; 1973 Sep; 98(35):1233-40. PubMed ID: 4361783
[No Abstract] [Full Text] [Related]
12. Cell cultures and their use in drug sensitivity prediction.
Dendy PP; Mitchell JS; Dawson A; Williamson J
Arch Geschwulstforsch; 1981; 51(1):111-8. PubMed ID: 7259433
[TBL] [Abstract][Full Text] [Related]
13. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
15. [Pretherapeutical testing of antineoplastic drugs in vitro (author's transl)].
Projan A; Tanneberger S; Peek U; Nissen E
Arch Geschwulstforsch; 1982; 52(1):1-7. PubMed ID: 7082128
[TBL] [Abstract][Full Text] [Related]
16. Short-term cultures of clinical tumor material: potential contributions to oncology research.
Baguley BC; Marshall ES; Finlay GJ
Oncol Res; 1999; 11(3):115-24. PubMed ID: 10527071
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy.
Blumenthal RD; Leone E; Goldenberg DM
Anticancer Res; 2003; 23(6C):4613-9. PubMed ID: 14981904
[TBL] [Abstract][Full Text] [Related]
19. [Improved efficacy of adjuvant chemotherapy by combination with immunostimulants].
Russchen CJ
Ned Tijdschr Geneeskd; 1990 Dec; 134(48):2323-5. PubMed ID: 2255371
[No Abstract] [Full Text] [Related]
20. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
